TAK:NYSE
Takeda Pharmaceutical Co Ltd
18,52ย US$
arrow_downward
-0,86%(-0,16) 1K
18,60ย US$
arrow_upward
+0,43% (+0,080)todayBirjadan oldin
Savdolar yopilgan: 13-okt, 16:00:06 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oสปzgartirishlar | Dinamika (%) |
|---|
insights_autoTAK tikeri uchun statistika yaratilmoqda...
Ochish
18,73ย US$
Yuqori
18,82ย US$
Past
18,52ย US$
Bozor kapitali
58,79ย mlrd
Oสปrtacha hajm
2,38ย mln
Hajmi
2,30ย ming
Dividend
3,40%
Choraklik dividendlar
0,16ย US$
Eks-dividend sanasi
29-sen, 2026
52 haftalik eng yuqori
19,10ย US$
52 haftalik eng past
12,99ย US$
Aksiya boสปyicha daromad
-0,33ย US$
Beta
-0,06
Muomaladagi aksiyalar
3,20ย mlrd
Xodimlar soni
47ย ming
Ochish
18,73ย US$
Yuqori
18,82ย US$
Past
18,52ย US$
Bozor kapitali
58,79ย mlrd
Oสปrtacha hajm
2,38ย mln
Hajmi
2,30ย ming
Dividend
3,40%
Choraklik dividendlar
0,16ย US$
Eks-dividend sanasi
29-sen, 2026
52 haftalik eng yuqori
19,10ย US$
52 haftalik eng past
12,99ย US$
Aksiya boสปyicha daromad
-0,33ย US$
Beta
-0,06
Muomaladagi aksiyalar
3,20ย mlrd
Xodimlar soni
47ย ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 soat oldin
Takeda reports psoriasis data: Takeda Pharmaceutical stock sits 3.04 percent below its high
Profil
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Takeda Pharmaceutical Co Ltd haqida
CEOChristophe Weber | Christophe Weber
Xodimlar soni47ย ming
Asos solingan12-iyn, 1781
Bosh ofislar-
Sektor-
Veb-sayttakeda.com